格力地产完成全资公司上海科华生物5%股份转让过户，携手致同本益共治生物产业
珠海保联 Investment Holding Co., Ltd., a fully-owned subsidiary of Gree Real Estate Corporation (the “Company”), has recently transferred 5% of the shares of Shanghai Kehua Biotechnology Co., Ltd. (“Shanghai Kehua”) to Zhe蒂en Beni Enterprise Partnership (Limited Partnership) (“Zhe蒂en Beni”). This move marks a significant change in the ownership structure of the biotech company and highlights the Company’s ongoing strategy of expanding its presence in the healthcare sector.
According to the company’s announcement on March 1st, the transfer was completed on January 11th. The deal was facilitated through an agreement between珠海保联 Investment Holding Co., Ltd. and Zhe蒂en Beni Enterprise Partnership (Limited Partnership). The agreement specified that珠海保联 would sell its 5% stake in Shanghai Kehua Biotechnology Co., Ltd. to Zhe蒂en Beni Enterprise Partnership (Limited Partnership) at a price of 20 RMB per share. In addition,珠海保联同意将其所持有的上海科华生物10.64%股份的表决权无偿、不可撤销地且唯一地委托给Zhe蒂en Beni Enterprise Partnership (Limited Partnership)行使。
The transaction is part of the Company’s long-term strategy of diversifying its business portfolio and expanding into new sectors. As a leading real estate developer in China, Gree Real Estate Corporation has been actively seeking opportunities to extend its reach beyond traditional property development. The acquisition of Shanghai Kehua Biotechnology Co., Ltd. represents a strategic step towards this goal, allowing the Company to leverage its expertise in healthcare to contribute to the development of innovative technologies and solutions.
Shanghai Kehua Biotechnology Co., Ltd. is a leading player in the biotech industry, specializing in the research, development, and production of cutting-edge medical products. By acquiring a controlling stake in the company,珠海保联 Investment Holding Co., Ltd. aims to leverage its strong scientific research capabilities, intellectual property assets, and experienced management team to drive growth and innovation within the healthcare sector.
The partnership between珠海保联 Investment Holding Co., Ltd. and Zhe蒂en Beni Enterprise Partnership (Limited Partnership) is expected to result in several benefits for both parties. For珠海保联, the sale of its stake in Shanghai Kehua Biotechnology Co., Ltd. will provide the company with much-needed capital to fund its growth plans and expand its product pipeline. Additionally, by transferring its shares to Zhe蒂en Beni Enterprise Partnership (Limited Partnership),珠海保联 will be able to focus on its core real estate businesses while benefiting from the expertise and resources of its new partner in the healthcare sector.
For Zhe蒂en Beni Enterprise Partnership (Limited Partnership), the acquisition of Shanghai Kehua Biotechnology Co., Ltd.’s shares will enable the company to strengthen its position as a leading player in the biotech industry. By partnering with珠海保联, Zhe蒂en Beni Enterprise Partnership (Limited Partnership) will gain access to a wealth of knowledge, resources, and expertise in healthcare, helping the company to develop innovative solutions and accelerate its growth. Moreover, the partnership will allow Zhe蒂en Beni Enterprise Partnership (Limited Partnership) to leverage珠海保联在资本市场的优势，为公司的进一步发展提供有力支持。
Upon completion of the registration process,珠海保联 Investment Holding Co., Ltd. will still hold approximately 70,150,000 shares of Shanghai Kehua Biotechnology Co., Ltd., accounting for 13.64% of the company’s total shares and 3% of its voting rights. Meanwhile, Zhe蒂en Beni Enterprise Partnership (Limited Partnership) will directly hold approximately 25,720,000 shares of Shanghai Kehua Biotechnology Co., Ltd., accounting for 5% of the company’s total shares and 10.64% of its voting rights. Through the voting rights entrusted to Zhe蒂en Beni Enterprise Partnership (Limited Partnership), the company will control approximately 80,440,000 shares of Shanghai Kehua Biotechnology Co., Ltd., accounting for 15.64% of the company’s total shares and 39.66% of its voting rights. During the voting rights entrustment period,珠海保联 Investment Holding Co., Ltd. will become a一致行动人 of Zhe蒂en Beni Enterprise Partnership (Limited Partnership).
The cooperation between珠海保联 Investment Holding Co., Ltd. and Zhe蒂en Beni Enterprise Partnership (Limited Partnership) is expected to herald a new chapter in the development of the healthcare sector. Both parties are committed to leveraging their respective strengths and expertise to create lasting value for their stakeholders, investors, and customers. As the healthcare industry continues to evolve, the partnership between珠海保联 Investment Holding Co., Ltd. and Zhe蒂en Beni Enterprise Partnership (Limited Partnership) is likely to play a crucial role in shaping the future of the sector and driving innovation forward.